Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit

Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit

We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of blaoxa-23-carrying sequence type 2 clone over...

Full description

Bibliographic Details
Main Authors: Amanda Chamieh, Tania Dagher Nawfal, Tala Ballouz, Claude Afif, George Juvelekian, Sani Hlais, Jean-Marc Rolain, Eid Azar
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2019-10-01
Series:Emerging Infectious Diseases
Subjects:
XDR
MDR
Acinetobacter baumanii
carbapenem
antimicrobial stewardship
antimicrobial resistance
Online Access:https://wwwnc.cdc.gov/eid/article/25/10/18-1626_article
Description
Summary:We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of blaoxa-23-carrying sequence type 2 clone over the 1-year study. Non–A. baumanii multidrug-resistant infections remained stable.
ISSN:1080-6040
1080-6059

Similar Items